ModAsian FINDRISC as a Screening Tool for People with Undiagnosed Type 2 Diabetes Mellitus in Vietnam: A Community-Based Cross-Sectional Study

References

• Bramlage P, Rey A, Thoenes M. Diabetes prevalence and metabolic risk profile in an unselected population visiting pharmacies in Switzerland. Vasc Health Risk Manag. 2012;541. doi:10.2147/VHRM.S35896
   PubMedGoogle Scholar
• Liu M, Pan C, Jin M; Chinese Diabetes A. Risk score for screening of undiagnosed diabetes and abnormal glucose tolerance. Diabetes Technol Ther. 2011;13(5):501–507. doi:10.1089/dia.2010.0106
   PubMed Web of Science ®Google Scholar
• Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024
   PubMed Web of Science ®Google Scholar
• Nnamudi AC, Orhue NEJ, Ijeh II. Assessment of the FINDRISC tool in predicting the risk of developing type 2 diabetes mellitus in a young adult Nigerian population. Bull Natl Res Cent. 2020;44(1):186. doi:10.1186/s42269-020-00440-7
   Google Scholar
• Levitt NS. Diabetes in Africa: epidemiology, management, and healthcare challenges. Heart. 2008;94(11):1376–1382. doi:10.1136/hrt.2008.147306
   PubMed Web of Science ®Google Scholar
• Selph S, Dana T, Blazina I, Bougatsos C, Patel H, Chou R. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive services task force. Ann Intern Med. 2015;162(11):765–776. doi:10.7326/M14-2221
   PubMed Web of Science ®Google Scholar
• Brown N, Critchley J, Bogowicz P, Mayige M, Unwin N. Risk scores based on self-reported or available clinical data to detect undiagnosed Type 2 Diabetes: a systematic review. Diabetes Res Clin Pract. 2012;98(3):369–385. doi:10.1016/j.diabres.2012.09.005
   PubMed Web of Science ®Google Scholar
• Paulweber B, Valensi P, Lindström J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res. 2010;42(S 01):S3–S36. doi:10.1055/s-0029-1240928
   PubMedGoogle Scholar
• Glümer C, Carstensen B, Sandbæk A, et al. Risk Score for Targeted Screening. Diabetes Care. 2004;27(3):727–733. doi:10.2337/diacare.27.3.727
   PubMed Web of Science ®Google Scholar
• Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–731. doi:10.2337/diacare.26.3.725
   PubMed Web of Science ®Google Scholar
• Zhou X, Qiao Q, Ji L, et al. Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey. Diabetes Care. 2013;36(12):3944–3952. doi:10.2337/dc13-0593
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study. BMJ. 2017;j5019. doi:10.1136/bmj.j5019
   PubMedGoogle Scholar
• Lindström J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230–3236. doi:10.2337/diacare.26.12.3230
   PubMed Web of Science ®Google Scholar
• Janghorbani M, Adineh H, Amini M. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome. Rev Diabet Stud RDS. 2013;10(4):283–292. doi:10.1900/RDS.2013.10.283
   PubMedGoogle Scholar
• Rodríguez MG, Saldaña MR, Leyva JMA, Rojas RM, Molina-Recio G. The FINDRISC questionnaire capacity to predict diabetes mellitus II, arterial hypertension and comorbidity in women from low-and-middle-income countries. Health Care Women Int. 2020;41(2):205–226. doi:10.1080/07399332.2019.1680678
   PubMed Web of Science ®Google Scholar
• Muñoz-González MC, Lima-Martínez MM, Nava A, et al. FINDRISC modified for Latin America as a screening tool for persons with impaired glucose metabolism in Ciudad Bolívar, Venezuela. Med Princ Pract. 2019;28(4):324–332. doi:10.1159/000499468
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med J Br Diabet Assoc. 2007;24(5):451–463. doi:10.1111/j.1464-5491.2007.02157.x
   PubMed Web of Science ®Google Scholar
• Roglic G. WHO Global report on diabetes: a summary. Int J Noncommunicable Dis. 2016;1(1):3. doi:10.4103/2468-8827.184853
   Google Scholar
• Rokhman MR, Arifin B, Zulkarnain Z, et al. Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population. PLoS One. 2022;17(7):e0269853. doi:10.1371/journal.pone.0269853
   PubMed Web of Science ®Google Scholar
• Lim HM, Chia YC, Koay ZL. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care. Prim Care Diabetes. 2020;14(5):494–500. doi:10.1016/j.pcd.2020.02.008
   PubMed Web of Science ®Google Scholar
• Châu LM, Cảnh ĐX. The prediction of type 2 diabetes for next years in 3 districts in Hung Yen province using the FINDRISC tool (Dự báo bệnh đái tháo đường typ 2 tại 3 huyện tỉnh Hưng Yên 10 năm theo thang điểm FINDRISC). Vietnam J Prev Med. 2019;29(2):52–59.
   Google Scholar
• Mai VQ, Đạt NV, Thiệu LH, et al. Prediction of undiagnosed diabetes and prediabetes by Findrisc scale in subjects over 45 years old in Khanh Hoa province (Dự báo tiền đái tháo đường và đái tháo đường không được chẩn đoán ở đối tượng trên 45 tuổi tại tỉnh Khánh Hòa theo thang điểm FINDRISC). Vietnam J Prev Med. 2017;28(8):95–102.
   Google Scholar
• Trần HD, Nguyễn ĐK. Study on the risk of diabetes by FINDRISC scale in hypertension patients (Nghiên cứu nguy cơ đái tháo đường theo thang điểm FINDRISC trên bệnh nhân tăng huyết áp). Vietnam J Diabetes Endocrinol. 2020;39:23–27. doi:10.47122/vjde.2020.39.3
   Google Scholar
• Vinh NT. Using FINDRISC in screening for type 2 diabetes (Sử dụng thang điểm FINDRISC trong sàng lọc đái tháo đường tuýp 2). Vietnam J Health Policy. 2020;30:69–75.
   Google Scholar
• Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014;48:193–204. doi:10.1016/j.jbi.2014.02.013
   PubMed Web of Science ®Google Scholar
• The Lancet Infectious Diseases. COVID-19: endgames. Lancet Infect Dis. 2020;20(5):511. doi:10.1016/S1473-3099(20)30298-X
   PubMed Web of Science ®Google Scholar
• Vietnamese Ministry of Health. Coronavirus disease (COVID-19) outbreak in Vietnam; 2020. Available from: https://ncov.moh.gov.vn/. Accessed April 5, 2022.
   Google Scholar
• World Health Organization. Novel coronavirus (2019-nCoV) technical guidance; 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance. Accessed April 5, 2022.
   Google Scholar
• Bui TV, Blizzard CL, Luong KN, et al. National survey of risk factors for non-communicable disease in Vietnam: prevalence estimates and an assessment of their validity. BMC Public Health. 2016;16:498. doi:10.1186/s12889-016-3160-4
   PubMed Web of Science ®Google Scholar
• World Health Organization, Regional Office for the Western Pacific, International Association for the Study of Obesity, International Obesity TaskForce. The Asia-Pacific Perspective: redefining Obesity and Its Treatment; 2002.
   Google Scholar
• Jølle A, Midthjell K, Holmen J, et al. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study. BMJ Open Diabetes Res Care. 2019;7(1):e000769. doi:10.1136/bmjdrc-2019-000769
   PubMed Web of Science ®Google Scholar
• Do IT, Tran HD, Ton TT, et al. Risk prediction model for type 2 diabetes mellitus using Finnish diabetes risk score (FINDRISC) among adult population in Da Nang city. Vietnam J Prev Med. 2017;2:137–141.
   Google Scholar
• Hageman S, Pennells L, Ojeda F; SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–2454. doi:10.1093/eurheartj/ehab309
   PubMed Web of Science ®Google Scholar
• de Vries TI, Cooney MT, Selmer RM; SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455–2467. doi:10.1093/eurheartj/ehab312
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang H, Cui N, et al. Development of a behavior change intervention to improve physical activity adherence in individuals with metabolic syndrome using the behavior change wheel. BMC Public Health. 2022;22(1):1740. doi:10.1186/s12889-022-14129-1
   PubMed Web of Science ®Google Scholar
• Lemstra M, Bird Y, Nwankwo C, Rogers M, Moraros J. Weight-loss intervention adherence and factors promoting adherence: a meta-analysis. Patient Prefer Adherence. 2016;10:1547–1559. doi:10.2147/PPA.S103649
   PubMed Web of Science ®Google Scholar
• Akinosun AS, Polson R, Diaz-Skeete Y, et al. Digital technology interventions for risk factor modification in patients with cardiovascular disease: systematic review and meta-analysis. JMIR MHealth UHealth. 2021;9(3):e21061. doi:10.2196/21061
   PubMed Web of Science ®Google Scholar
• Hinchliffe N, Capehorn MS, Bewick M, Feenie J. The potential role of digital health in obesity care. Adv Ther. 2022;39(10):4397–4412. doi:10.1007/s12325-022-02265-4
   PubMed Web of Science ®Google Scholar